Pharmalogic ApS: Financial statements 2024
CVR: 42323519
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmalogic ApS (CVR 42323519) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 19,842,654 and a net result of DKK -693,511 compared with DKK 1,293,878 the year before. That is an increase of 32.6% compared with the year before. Equity in the 2024 report amounted to DKK 242,431. The solvency ratio was 3.8%. The company had 24 employees in the financial year.
- Gross Profit
- DKK 19,842,654
- Profit/Loss
- DKK -693,511
- Equity
- DKK 242,431
- Total Assets
- DKK 6,410,098
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 19.8 mio. | -694 t. | 242 t. | 24 |
| 2023 | - | 15 mio. | 1.3 mio. | 1.9 mio. | 11 |
| 2022 | - | 7.4 mio. | 578 t. | 1.1 mio. | 7 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmalogic ApS has published its annual report for 2023. Gross profit came to DKK 14,960,830, and the net result was DKK 1,293,878.
About Pharmalogic ApS
Pharmalogic ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Tanja Dybdal Beck and Allan Christian Beck. The company is owned by DYBDAL BECK INVEST ApS. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK 25,106,323 and a net result of DKK 1,079,238 compared with DKK -693,511 the year before. Equity in the 2025 report amounted to DKK 1,340,263.